{
    "Trade/Device Name(s)": [
        "SeraQuest EBV EA-D IgG",
        "Epstein-Barr virus serological reagents"
    ],
    "Submitter Information": "Quest International, Inc.",
    "510(k) Number": "K091260",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "LSE"
    ],
    "Summary Letter Date": "June 8, 2009",
    "Summary Letter Received Date": "April 29, 2009",
    "Submission Date": "April 3, 2009",
    "Regulation Number(s)": [
        "21CFR866.3235"
    ],
    "Regulation Name(s)": [
        "Multiple antibodies immunological test system"
    ],
    "Analyte Class(es)": [
        "immunology",
        "virology",
        "serology"
    ],
    "Analyte(s)": [
        "IgG antibodies to Epstein-Barr virus early antigen diffuse (EA-D)"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Enzyme immunoassay (EIA)",
        "Microwell assay"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Assay",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for SeraQuest EBV EA-D IgG enzyme immunoassay for qualitative detection of IgG antibodies to EBV EA-D in human serum",
    "Indications for Use Summary": "Qualitative detection of human IgG antibodies to Epstein-Barr virus early antigen diffuse (EA-D) in serum by enzyme immunoassay, as an aid in laboratory diagnosis of EBV infectious mononucleosis in symptomatic patients, used in conjunction with other EBV serological tests",
    "fda_folder": "Microbiology"
}